The Valley Desk

Clinical trial reportJournal of affective disordersPublished

Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of affective disorders
Published
Subject terms
Humans; Antidepressive Agents; Delayed-Action Preparations; Treatment Outcome; Combined Modality Therapy; Drug Therapy, Combination; Cognition; Adult; Middle Aged; Female; Male; Transcranial Magnetic Stimulation
PubMed ID
40633778
Added to directory
Source checked

Report a correction or request removal